4//SEC Filing
Tada Hiroomi 4
Accession 0001209191-23-044047
CIK 0001863127other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:41 PM ET
Size
5.4 KB
Accession
0001209191-23-044047
Insider Transaction Report
Form 4
Tada Hiroomi
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-28+115,000→ 115,000 totalExercise: $14.35Exp: 2033-07-27→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest monthly following July 28, 2023, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001880593
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:41 PM ET
- Size
- 5.4 KB